Jason B. Shandell

2020

In 2020, Jason B. Shandell earned a total compensation of $6.8M as Former President, General Counsel and Director at Amphastar Pharmaceuticals, a 132% increase compared to previous year.

Compensation breakdown

Bonus$15,000
Option Awards$1,557,068
Salary$229,094
Stock Awards$2,441,097
Other$2,543,898
Total$6,786,157

Shandell received $2.5M in other compensation, accounting for 37% of the total pay in 2020.

Shandell also received $15K in bonus, $1.6M in option awards, $229.1K in salary and $2.4M in stock awards.

Rankings

In 2020, Jason B. Shandell's compensation ranked 1,457th out of 13,090 executives tracked by ExecPay. In other words, Shandell earned more than 88.9% of executives.

ClassificationRankingPercentile
All
1,457
out of 13,090
89th
Division
Manufacturing
541
out of 5,620
90th
Major group
Chemicals And Allied Products
196
out of 2,253
91st
Industry group
Drugs
164
out of 1,953
92nd
Industry
Pharmaceutical Preparations
114
out of 1,458
92nd

Pay ratio

Jason B. Shandell's Pay$6,786,157
Median Employee's Pay$46,374
Pay Ratio

146

to 1

In 2020, the annual total compensation of Jason B. Shandell was $6,786,157.

The annual total compensation of the median employee at Amphastar Pharmaceuticals was $46,374.

The ratio of Jason B. Shandell's pay to the pay of median employee was therefore 146 to one.

Source: SEC filing on April 14, 2021.

Shandell's colleagues

We found five more compensation records of executives who worked with Jason B. Shandell at Amphastar Pharmaceuticals in 2020.

2020

Jack Zhang

Amphastar Pharmaceuticals

Chief Executive Officer

2020

Mary Luo

Amphastar Pharmaceuticals

Chief Operating Officer

2020

William Peters

Amphastar Pharmaceuticals

Chief Financial Officer

2020

Rong Zhou

Amphastar Pharmaceuticals

Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc

2020

Jacob Liawatidewi

Amphastar Pharmaceuticals

Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S

News

You may also like